Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Immunovant, Inc. | Chief Technology Officer | Common Stock | 142K | $4.2M | $29.53 | Oct 23, 2024 | Direct |
Immunovant, Inc. | Chief Technology Officer | Stock Option (right to buy) | 68.7K | Apr 2, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
IMVT | Immunovant, Inc. | Oct 23, 2024 | 1 | -$80.9K | 4 | Oct 25, 2024 | Chief Technology Officer |
IMVT | Immunovant, Inc. | Jul 24, 2024 | 1 | -$78.1K | 4 | Jul 26, 2024 | Chief Technology Officer |
IMVT | Immunovant, Inc. | Apr 24, 2024 | 1 | -$209K | 4 | Apr 26, 2024 | Chief Technology Officer |
IMVT | Immunovant, Inc. | Apr 2, 2024 | 2 | $0 | 4 | Apr 4, 2024 | Chief Technology Officer |
IMVT | Immunovant, Inc. | Apr 17, 2023 | 2 | $0 | 4 | Apr 19, 2023 | Chief Technology Officer |
IMVT | Immunovant, Inc. | Apr 17, 2023 | 0 | $0 | 3 | Apr 19, 2023 | Chief Technology Officer |